Skip to main content
. 2017 Jul 25;2(7):3828–3838. doi: 10.1021/acsomega.7b00020

Figure 4.

Figure 4

Chemical structures of purvalanol B (3), sunitinib (4), dasatinib (5) (the modified compounds for NHS-sepharose affixing are 6, 7, and 8, respectively) CTx-0294885 (9), and the Kuster compound 19 (KC19; 10). The highlighted NH2 moieties represent the point of NHS-sepharose bead attachment.